Press Releases Jazz Pharmaceuticals plc Sao Paulo

Equities

J2AZ34

BRJ2AZBDR009

Market Closed - Sao Paulo Other stock markets 06:47:51 10/05/2024 pm IST			5-day change	1st Jan Change
38.72 ^BRL	-0.56%		-.--%	-10.95%

01/07	Jazz Pharmaceuticals plc(NasdaqGS:JAZZ) dropped from Russell 3000 Growth Index	CI
01/07	Jazz Pharmaceuticals plc(NasdaqGS:JAZZ) dropped from Russell Small Cap Comp Growth Index	CI

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Jazz Pharmaceuticals Provides Update on Phase 2b Trial of Investigational Suvecaltamide (JZP385) in Essential Tremor	20/06	PR
Jazz Pharmaceuticals : 2023 Annual Report	15/06	PU
Surging Biotech M&A Reaffirms Massive Opportunity In Rare Disease Drug Development (CRDL,JAZZ, NVO, AZN, SNY)	11/06	AQ
Jazz Pharmaceuticals plc - Zanidatamab Granted Priority Review for HER2-Positive Metastatic Biliary Tract Cancer	30/05	AQ
Jazz Pharmaceuticals Showcases Pioneering Research in Sleep Medicine at SLEEP 2024	30/05	PR
Jazz Pharmaceuticals to Participate in Upcoming June Investor Conferences	30/05	PR
Jazz Pharmaceuticals Announces Collaboration with Life Science Cares to Improve the Wellbeing of Under Resourced Communities through Employee Volunteerism	22/05	PR
Jazz Pharmaceuticals : Corporate Overview	04/05	PU
Jazz Pharmaceuticals : Announces First Quarter 2024 Financial Results	02/05	PU
Jazz: Q1 Earnings Snapshot	02/05	AQ
Jazz Pharmaceuticals to Participate in the BofA Securities 2024 Health Care Conference	02/05	PR
Jazz Pharmaceuticals Announces First Quarter 2024 Financial Results and Affirms 2024 Financial Guidance	02/05	PR
Jazz Pharmaceuticals to Present Data across Growing Oncology Pipeline and Portfolio at ASCO 2024	25/04	AQ
The PharmaMar Group presents financial results for the first quarter of 2024	24/04	AQ
Jazz Pharmaceuticals to Report 2024 First Quarter Financial Results on May 1, 2024	18/04	PR
Jazz Pharmaceuticals : Zanidatamab R&D Day	19/03	PU
Jazz Pharmaceuticals to Host Virtual Zanidatamab R&D Day on Tuesday, March 19, 2024	13/03	PR
Agrify Corp Stock Presents Compelling Opportunity As Deal Flow Intensifies ($AGFY)	07/03	AQ
Jazz Pharmaceuticals : Corporate Overview	02/03	PU
Jazz: Q4 Earnings Snapshot	29/02	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Jazz Pharmaceuticals plc Sao Paulo

Equities

J2AZ34

BRJ2AZBDR009

Press Releases

Filters